Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Lovaness Limited has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This activity is localized with 1 distinct examiner and a distinct art unit, showing a concentrated prosecution effort. This suggests that the company's current legal focus at the USPTO is directed toward a specific biological or pharmaceutical invention. The narrow scope of the portfolio means that the company's immediate success in the biotechnology sector is dependent on the review of this examiner.
The busiest examiner, HUI, SAN MING R, is responsible for the pending office action. This matter represents the total active volume for the company's portfolio. Practitioners should focus on the specific requirements of this examiner, as their review will determine the immediate outcome for the company's 1 pending office action. Navigating the standards of the involved art unit is essential for securing the company's pharmaceutical intellectual property under the guidance of this examiner.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HUI, SAN MING R | 1 | 59.6% | +20.0% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18704777 | FORTIFIED WATER | HUI, SAN MING R | — |
| Art Unit | Apps |
|---|---|
| 1627 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18704777 | FORTIFIED WATER | HUI, SAN MING R | 1627 | §103 | Non-Final OA | — | Pending | Apr 25, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialLovaness Limited has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
San Ming R Hui has the most, with 1 of Lovaness Limited's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
